Richard Bryce

Richard Paul Bryce is currently a Member of the American Society of Clinical Oncology, Inc., the Royal College of Physicians, the American Association for Cancer Research, the American Society of Hematology, the European Society for Medical Oncology, and the Royal College of General Practitioners.
He is also the Chief Medical Officer at enGene, Inc. starting in 2023.
In his former positions, Dr. Bryce served as the Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2008 to 2012.
He was also the Director-Medical Affairs & Oncology at ICON plc from 2007 to 2008, and the Senior Director-Medical Affairs & Oncology at ICON Clinical Research, Inc. during the same period.
From 2012 to 2021, he held the position of Chief Medical & Scientific Officer at Puma Biotechnology, Inc. Additionally, he served as the President & Executive VP-Medical Affairs at Ergomed Plc from 2005 to 2007.
He was the Chief Medical Officer at Rain Oncology, Inc. from 2021 to 2023, and the Chief Medical Officer at enGene Holdings, Inc. from 2023 to 2024.
Dr. Bryce obtained his undergraduate and doctorate degrees from The University of Edinburgh in 1981.